| 2005N-0345 | Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product | |||||||||||||||||||||||
| FDA Comment Number : | EC11 | |||||||||||||||||||||||
| Submitter : | Mr. William Rivkin | Date & Time: | 09/01/2005 04:09:54 | |||||||||||||||||||||
| Organization : | Mr. William Rivkin | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| This drug has been proven to be safe and effective. There is no scientific reason why it cannot sold over the counter. By playing politics with this drug the FDA is doing a great disservice to the American people. | ||||||||||||||||||||||||